W STRATEGIES, LLC for ABBVIE INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
Monitored legislative efforts to reform the corporate tax system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013. S. 957: Drug Supply Chain Security Act. S. 959: Pharmaceutical Compounding Quality and Accountability Act. H.R. 3089: Compounding Clarity Act of 2013.H.R. 3204: The Drug Quality and Security Act. Education and outreach regarding proposed legislation to promote HCV testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.